10-year

10-Year Anniversary Promotion (20% off)

Join GuruFocus Premium Membership Now for Only $279/Year

Once a decade discount

Save up to $500 on Global Membership.

Don't Miss It !

Free 7-day Trial
All Articles and Columns »

Weekly CFO Buys Highlight: Ocean BioChem, Solarwinds Inc., PDL BioPharma, Autobytel Inc., Affymetrix Inc., Apollo Investment, General Moly Inc.

Gurujk

Gurujk

5 followers
According to GuruFocus Insider Data, the largest CFO buys during the past week were Ocean BioChem Inc. (OBCI), Solarwinds Inc. (SWI), PDL BioPharma Inc. (PDLI), Autobytel Inc. (ABTL), Affymetrix Inc. (AFFX), Apollo Investment Corp. (AINV), and GENERAL MOLY, INC (GMO).

CFO of Ocean BioChem Inc. (OBCI) Jeffrey Barocas bought 34,000 shares during the past week at an average price of $2.05. OCEAN BIO-CHEM, INC. is principally engaged in the marketing and distribution of a broad line of appearance and maintenance products for automobiles, boats, motorcycles, recreational vehicles and aircraft under the Star Brite name. Ocean Biochem Inc. has a market cap of $16.1 million; its shares were traded at around $2.1 with a P/E ratio of 13.1 and P/S ratio of 0.7.

CEO, 10% Owner Peter G Dornau, CFO Jeffrey Barocas, and Vice President William Dudman bought shares of OBCI stock.

Solarwinds Inc. (SWI): Senior Vice President & CFO Michael J Berry Bought 15,000 Shares

Senior Vice President & CFO of Solarwinds Inc. (SWI) Michael J Berry bought 15,000 shares on 04/29/2010 at an average price of $19.28. SolarWinds, Inc., headquartered in Austin, Texas, provides powerful, simple and affordable network management software to more than 80,000 customers worldwide -- from Fortune 500 enterprises to small businesses. Solarwinds Inc. has a market cap of $1.23 billion; its shares were traded at around $18.19 with a P/E ratio of 34.3 and P/S ratio of 10.5.

SolarWinds, Inc. reported results for its first quarter ended March 31, 2010. SolarWinds reported record quarterly total revenue in the first quarter of 2010 of $34.3 million, a 43% year-over-year increase over total revenue in the first quarter of 2009. Non-GAAP net income was $11.4 million in the first quarter of 2010, or $0.16 per diluted share, compared to $7.6 million in the first quarter of 2009, or $0.12 per diluted share, representing a 51% year-over-year increase in Non-GAAP net income.

SWI is in the portfolios of RS Investment Management, Steven Cohen of SAC Capital Advisors.

President, COO, CFO & Treas Kevin B Thompson, Senior VP, Engineering Douglas G Hibberd, and VP, HR & Corp Infrastructure Garry D Strop sold shares of SWI stock.

PDL BioPharma Inc. (PDLI): Vice President and CFO Christine R Larson Bought 10,000 Shares

Vice President and CFO of PDL BioPharma Inc. (PDLI) Christine R Larson bought 10,000 shares on 04/30/2010 at an average price of $6.18. Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. Pdl Biopharma Inc. has a market cap of $712 million; its shares were traded at around $5.95 with a P/E ratio of 5.7 and P/S ratio of 2.2. The dividend yield of Pdl Biopharma Inc. stocks is 16.7%.

PDL BioPharma, Inc. total revenues for the first quarter of 2010 were $62.1 million, compared with $62.6 million for the same period of 2009. Net income for the first quarter of 2010 was $26.0 million, or $0.15 per diluted share, compared with net income of $37.5 million, or $0.23 per diluted share, for the same period in 2009.

PDLI is in the portfolios of Jim Simons of Renaissance Technologies LLC, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, David Dreman of Dreman Value Management, Paul Tudor Jones of The Tudor Group, Bruce Kovner of Caxton Associates, Steven Cohen of SAC Capital Advisors, George Soros of Soros Fund Management LLC.

Vice President and CFO Christine R Larson bought shares of PDLI stock.

Autobytel Inc. (ABTL): SVP & CFO Curtis E Dewalt Bought 5,560 Shares

SVP & CFO of Autobytel Inc. (ABTL) Curtis E Dewalt bought 5,560 shares on 05/04/2010 at an average price of $0.9. Autobytel, Inc. is an internationally branded online automotive commerce company that provides consumers with automotive solutions throughout the lifecycle of vehicle ownership. Autobytel Inc. has a market cap of $47.6 million; its shares were traded at around $1.05 with and P/S ratio of 0.9.

Autobytel Inc. reported financial results for the first quarter ended March 31, 2010. The company reported net income of $797,000, or $0.02 per diluted share, for the first quarter of 2010, compared with a net loss of $357,000, or $0.01 per share, for the prior year period. Revenue for the 2010 first quarter totaled $11.8 million, down from $13.9 million for the 2009 first quarter.

ABTL is in the portfolios of Chuck Royce of Royce& Associates, Jim Simons of Renaissance Technologies LLC.

President & CEO Jeffrey H Coats, SVP & CFO Curtis E Dewalt, and V.P. & Controller Wesley Ozima bought shres of ABTL stock.

Affymetrix Inc. (AFFX): CFO Timothy C Barabe Bought 5,000 Shares

CFO of Affymetrix Inc. (AFFX) Timothy C Barabe bought 5,000 shares on 04/27/2010 at an average price of $6.45. Affymetrix scientists invented the world's first high-density microarray and began selling the first commercial microarray. Affymetrix Inc. has a market cap of $434.6 million; its shares were traded at around $6.13 with and P/S ratio of 1.4.

Affymetrix, Inc. reported its operating results for the first quarter of 2010. Total revenue for the quarter was $80.2 million, as compared to total revenue of $78.6 million in the first quarter of 2009. The Company reported a net loss of approximately $9.6 million, or $0.14 per diluted share, in the first quarter of 2010 which included an impairment charge of $4.9 million, or $0.07 per diluted share, on a nonmarketable investment. This compares to net loss of $25.2 million, or $0.37 per diluted share, in the same period of 2009 which included a pretax restructuring charge of $2.0 million, or $0.03 per diluted share.

AFFX is in the portfolios of Chuck Royce of Royce& Associates, PRIMECAP Management, Jim Simons of Renaissance Technologies LLC, Steven Cohen of SAC Capital Advisors.

CFO Timothy C Barabe bought shares of AFFX stock.

Apollo Investment Corp. (AINV): CFO and Treasurer Richard Peteka Bought 5,000 Shares

CFO and Treasurer of Apollo Investment Corp. (AINV) Richard Peteka bought 5,000 shares on 04/28/2010 at an average price of $12.2. Apollo Investment Corporation is a closed-end investment company that has elected to be treated as a business development company under the Investment Company Act of 1940. Apollo Investment Corp. has a market cap of $1.86 billion; its shares were traded at around $10.58 with a P/E ratio of 7.8 and P/S ratio of 5.1. The dividend yield of Apollo Investment Corp. stocks is 10.6%. Apollo Investment Corp. had an annual average earning growth of 38.5% over the past 5 years.

Apollo Investment Corporation announced financial results for its fiscal quarter ended December 31, 2009. Additionally, Apollo Investment Corporation announces that its Board of Directors has declared its fourth fiscal quarter 2010 dividend of $0.28 per share, payable on April 2, 2010 to stockholders of record as of March 18, 2010. The company reported total assets of $3.4 billion and net assets of $1.8 billion.

AINV is in the portfolios of David Williams of Columbia Value and Restructuring Fund, Paul Tudor Jones of The Tudor Group, Chuck Royce of Royce& Associates, Murray Stahl of Horizon Asset Management, Steven Cohen of SAC Capital Advisors.

CEO James C Zelter, CFO and Treasurer Richard Peteka, and President & COO Patrick J Dalton bought shares of AINV stock.

GENERAL MOLY, INC (GMO): CFO David Chaput Bought 5,000 Shares

CFO of GENERAL MOLY, INC (GMO) David Chaput bought 5,000 shares on 04/30/2010 at an average price of $3.89. General Moly is a U.S.-based molybdenum mineral exploration and development company listed on the American Stock Exchange and the Toronto Stock Exchange under the symbol GMO. General Moly, Inc has a market cap of $259 million; its shares were traded at around $3.57.

General Moly announced its unaudited financial results for the first quarter ended March 31, 2010. Net loss for the three months ended March 31, 2010 was approximately $2.8 million ($0.04 per share), compared to a loss of $3.0 million ($0.04 per share) for the year ago period.

GMO is in the portfolios of Jim Simons of Renaissance Technologies LLC.

CEO Bruce D Hansen, CFO David Chaput, Director Jean Pierre Ergas bought shares of GMO stock.

For the complete list of stocks that bought by their CFOs, go to: Insider Buys.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 2.3/5 (3 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK